Abstract: A chewable composition for treating pharyngeal inflammation is provided that includes a first chewable prostaglandin inhibitor tablet that includes a prostaglandin inhibitor along with those excipients needed to form a compressed chewable tablet. The first chewable tablet is devoid of ascorbic acid, citric acid, and zinc cations. A second chewable supplement tablet of the composition includes an immune system activating organic acid of ascorbic acid, citric acid, or a combination thereof. The second chewable supplement tablet also includes zinc cations. The components of the second chewable supplement tablet are readily segregated into multiple tablets, with each of the multiple tablets containing similar or dissimilar active ingredient constituents and concentrations.